<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Med</journal-id><journal-id journal-id-type="iso-abbrev">J Clin Med</journal-id><journal-id journal-id-type="pmc-domain-id">2745</journal-id><journal-id journal-id-type="pmc-domain">jclinmed</journal-id><journal-id journal-id-type="publisher-id">jcm</journal-id><journal-title-group><journal-title>Journal of Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2077-0383</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11277864</article-id><article-id pub-id-type="pmcid-ver">PMC11277864.1</article-id><article-id pub-id-type="pmcaid">11277864</article-id><article-id pub-id-type="pmcaiid">11277864</article-id><article-id pub-id-type="pmid">39064219</article-id><article-id pub-id-type="doi">10.3390/jcm13144179</article-id><article-id pub-id-type="publisher-id">jcm-13-04179</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Adverse Events in Open Surgical vs. Ultrasound-Guided Percutaneous Brachial Access for Endovascular Interventions</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6151-2147</contrib-id><name name-style="western"><surname>Ozcinar</surname><given-names initials="E">Evren</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><xref rid="af1-jcm-13-04179" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7515-8465</contrib-id><name name-style="western"><surname>Dikmen</surname><given-names initials="N">Nur</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af1-jcm-13-04179" ref-type="aff">1</xref><xref rid="c1-jcm-13-04179" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1875-6258</contrib-id><name name-style="western"><surname>Kayan</surname><given-names initials="A">Ahmet</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af2-jcm-13-04179" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Baran</surname><given-names initials="C">Cagdas</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-jcm-13-04179" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yazicioglu</surname><given-names initials="L">Levent</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-jcm-13-04179" ref-type="aff">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Anderson</surname><given-names initials="JL">Jeffrey L.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-jcm-13-04179"><label>1</label>Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara 06230, Turkey; <email>evrenozcinar@gmail.com</email> (E.O.); <email>cagdasbaran@gmail.com</email> (C.B.); <email>leventyazicioglu@gmail.com</email> (L.Y.)</aff><aff id="af2-jcm-13-04179"><label>2</label>Department of Cardiovascular Surgery, Kirikkale High Specialization Hospital, Kirikkale 71300, Turkey; <email>dr.ahmet.kayan@gmail.com</email></aff><author-notes><corresp id="c1-jcm-13-04179"><label>*</label>Correspondence: <email>nurdikmen@yahoo.com</email>; Tel.: +90-533-4697923</corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>7</month><year>2024</year></pub-date><volume>13</volume><issue>14</issue><issue-id pub-id-type="pmc-issue-id">467554</issue-id><elocation-id>4179</elocation-id><history><date date-type="received"><day>29</day><month>5</month><year>2024</year></date><date date-type="rev-recd"><day>08</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>13</day><month>7</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>17</day><month>07</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>27</day><month>07</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-07-28 09:25:21.137"><day>28</day><month>07</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jcm-13-04179.pdf"/><abstract><p><bold>Background:</bold> Advances in endovascular interventions have made endovascular approaches the first option for treating peripheral arterial diseases. Although radial artery access is commonly used for coronary procedures, the common femoral artery remains the most frequent site for endovascular treatments due to better ergonomics and proven technical success. Meanwhile, data on using upper extremity access via the brachial artery during complex endovascular aortic interventions are lacking. This study aimed to compare the incidence of access site complications between ultrasound-guided percutaneous brachial access (UPA) and open surgical incisional brachial access (OSA) in the management of peripheral arterial diseases. <bold>Methods:</bold> Patients who underwent treatment for peripheral arterial and aortic disease using brachial access from 2019 to 2023 were included in this study. The primary endpoint was the complication rate at the access site 30 days postoperatively. Access-related complications included bleeding requiring re-exploration, acute upper limb ischemia, thrombosis, pseudoaneurysm, arteriovenous fistula, and nerve injury associated with the brachial access. <bold>Results:</bold> Brachial access was performed on 485 patients (UPA, <italic toggle="yes">n</italic> = 320; OSA, <italic toggle="yes">n</italic> = 165). The mean operation time was 164.5 &#177; 45.4 min for the percutaneous procedure and 289.2 &#177; 79.4 min for the cutdown procedure (<italic toggle="yes">p</italic> = 0.003). Postprocedural hematoma occurred in 15 patients in the UPA group and 2 patients in the OSA group (<italic toggle="yes">p</italic> = 0.004). Thromboembolic events were observed in 9 patients in the percutaneous group and 3 patients in the OSA group. Reoperation was required for 23 patients in the percutaneous group and 8 patients in the cutdown group. <bold>Conclusions:</bold> The findings indicate that patients undergoing endovascular arterial interventions have a higher rate of brachial access complications in the UPA group compared to the OSA group.</p></abstract><kwd-group><kwd>access site complications</kwd><kwd>ultrasound guidance</kwd><kwd>peripheral arterial disease</kwd><kwd>open surgical incision</kwd><kwd>endovascular interventions</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-jcm-13-04179"><title>1. Introduction</title><p>Advances in endovascular interventions have made endovascular approaches the first choice for treating peripheral arterial diseases [<xref rid="B1-jcm-13-04179" ref-type="bibr">1</xref>]. Although radial artery access is preferred for coronary artery procedures, the common femoral artery remains the most commonly used site for endovascular treatments in peripheral arterial interventions [<xref rid="B2-jcm-13-04179" ref-type="bibr">2</xref>]. This preference is due to the superior ergonomics and proven technical success associated with femoral access, leading to a significant portion of peripheral and aortic pathologies being managed through this route. However, brachial access is emerging as a viable alternative, especially for lesions involving renovisceral arteries, given the downward and angulated pattern of this arterial tree [<xref rid="B3-jcm-13-04179" ref-type="bibr">3</xref>]. Brachial artery access offers advantages for visceral artery revascularization and serves as an alternative in cases where the femoral approach is unsuitable due to prior endovascular or open procedures. Upper extremity access (UEA) via the brachial artery is routinely employed in several complex procedures, particularly those involving the incorporation of renal and splanchnic vessels, such as parallel grafts and branched and fenestrated endovascular procedures. Additionally, the instructions for using off-the-shelf branched stent grafts for treating thoracoabdominal aortic aneurysms recommend antegrade deployment of target vessel bridging stents via UEA. Furthermore, the treatment of aortoiliac occlusive disease, such as covered endovascular reconstruction of aortic bifurcation (CERAB), can be a potential route for addressing more severe occlusive disease extending to the renal artery level or completely occluded iliac lesions that cannot be accessed through the femoral artery [<xref rid="B4-jcm-13-04179" ref-type="bibr">4</xref>,<xref rid="B5-jcm-13-04179" ref-type="bibr">5</xref>]. Access through the upper extremity may lead to complications such as bleeding, hematomas, or thrombosis due to the smaller diameter of the brachial artery [<xref rid="B6-jcm-13-04179" ref-type="bibr">6</xref>]. Both open surgical cutdown brachial access (OSA) and ultrasound-guided percutaneous brachial access (UPA) can achieve arterial access. However, percutaneous interventions have been associated with fewer complications in previous studies [<xref rid="B7-jcm-13-04179" ref-type="bibr">7</xref>]. This study aims to compare the outcomes of OSA and UPA in treating peripheral vascular and aortic diseases.</p></sec><sec id="sec2-jcm-13-04179"><title>2. Material and Methods</title><sec id="sec2dot1-jcm-13-04179"><title>2.1. Study Design</title><p>This retrospective observational study investigates the outcomes of OSA and UPA in managing peripheral arterial and aortic disease. Data were collected from our tertiary academic referral center between 2019 and 2023. This study was approved by the institutional review board and the Ankara University Faculty of Medicine Human Research Ethics Committee (date: 28 August 2023, no. 2023/398).</p><p>Individuals over 18 years of age requiring brachial access for peripheral arterial or aortic interventions were eligible for inclusion. Patients with a previous vascular graft (e.g., patch) at the access site were excluded from this study. The physician reviewed the indications for brachial artery access and its viability at the time of the initial procedure, and no patients were excluded retrospectively based on the anatomy of the access vessel. Patients were excluded if the brachial access intervention was used for diagnostic purposes only.</p><p>Patient-specific variables were extracted from hospital records. Data included age, gender, body mass index (BMI in kg/m<sup>2</sup>), chronic obstructive pulmonary disease (COPD), smoking status, hypertension, cerebrovascular disease, diabetes mellitus (DM), coronary artery disease (CAD), and renal disease (estimated glomerular filtration rate &lt; 60 mL/min/1.73 m<sup>2</sup>). Preoperative use of ACE inhibitors, beta-blockers, calcium antagonists, diuretics, acetylsalicylic acid, clopidogrel, and anticoagulants was also recorded. Additionally, procedural time, arterial access method, and sheath size were assessed.</p></sec><sec id="sec2dot2-jcm-13-04179"><title>2.2. Operative Technique</title><p>All procedures were performed by the same cardiovascular surgeons in a hybrid room with the aid of fluoroscopic guidance. The decision to use the brachial access route and the choice between the OSA and UPA methods were based on the physicians&#8217; preferences. For percutaneous access, brachial artery punctures were performed at the olecranon fossa level to allow better vessel compression with ultrasound guidance [<xref rid="B6-jcm-13-04179" ref-type="bibr">6</xref>]. After sheath placement, patients were heparinized to achieve a target activated clotting time (ACT) above 250 s. The patients regularly receiving oral anticoagulation therapy stopped treatment two days before the intervention, and the antiplatelet drugs were resumed upon hospitalization. No arterial closure devices were utilized.</p><p>The manual compression and immobilization of the elbow joint were maintained for 12 h in the UPA procedures. In the OSA method, the arterial puncture was closed with a 6-0 polypropylene suture in a separate manner. Clinical examinations were conducted at 1 h, 6 h, 1 day, 2 weeks, and 30 days after the procedure. During the follow-up period, decisions for re-exploration were made based on physician assessment in cases of hematoma, ischemia, and neuropathy. All the patients underwent duplex ultrasound examinations at 1 day, 15 days, and 30 days postoperatively. Dual antiplatelet therapy for at least 6 months or a combination of an oral anticoagulant and an antiplatelet regimen was prescribed postoperatively for both methods. </p></sec><sec id="sec2dot3-jcm-13-04179"><title>2.3. Endpoints and Definitions</title><p>The primary endpoint was the complication rate at the access site 30 days postoperatively. Access-related complications included bleeding requiring re-exploration, acute upper limb ischemia, thrombosis, pseudoaneurysm, arteriovenous fistula, and nerve injury associated with brachial access.</p><p>The secondary outcomes included major adverse events and minor access-site vascular complications (infection, deep venous thrombosis, hematoma, arteriovenous fistula, and transient peripheral nerve injury) not requiring additional surgeries, as well as the type and incidence of open or endovascular adjunctive procedures at the access site. Major adverse events at 30 days included myocardial infarction, death, and cerebrovascular events. Stroke was defined as a new acute ischemic lesion diagnosed by cerebral imaging modalities. TIA was defined as a transient focal neurologic deficit with complete resolution within 24 h and no new ischemic lesion evident on cerebral imaging. Myocardial infarction was defined by ischemic symptoms such as chest pain, ST-segment elevation of &gt;1 mm in two or more leads, and troponin levels more than twice the normal limit. </p></sec><sec id="sec2dot4-jcm-13-04179"><title>2.4. Statistical Analysis</title><p>All statistical analyses were performed using SPSS version 28.0 (IBM). Continuous variables were expressed as mean &#177; standard deviation and categorical variables as counts and percentages. Continuous data were compared using Student&#8217;s <italic toggle="yes">t</italic> test, and categorical data were compared using Fisher&#8217;s exact test. An &#945;-value of 0.05 was set as the threshold for statistical significance.</p></sec></sec><sec sec-type="results" id="sec3-jcm-13-04179"><title>3. Results</title><p>In our single-center retrospective study, we analyzed 485 patients. The preoperative baseline clinical and demographic characteristics of the patients are presented in <xref rid="jcm-13-04179-t001" ref-type="table">Table 1</xref>. Most of the patients were men (<italic toggle="yes">n</italic> = 182, 56.9% for UPA vs. <italic toggle="yes">n</italic> = 99, 60% for OSA), with a mean age of 67.2 years in UPA and 69.4 years in OSA. The mean BMI was similar in both groups. Preoperative data such as smoking, diabetes, COPD, and hypertension had similar rates when compared in both groups and were statistically insignificant (<italic toggle="yes">p</italic> &gt; 0.05) (<xref rid="jcm-13-04179-t001" ref-type="table">Table 1</xref>). We also compared the preoperative use of antiaggregants and anticoagulants in both patient groups, and the rates were similar and statistically insignificant (<italic toggle="yes">p</italic> &gt; 0.05). Peripheral arterial diseases involving the common femoral artery, superficial femoral artery, and external iliac artery, as well as combinations of these locations, were the most common lesion treated (UPA <italic toggle="yes">n</italic> = 216 vs. OSA <italic toggle="yes">n</italic> = 45); the second most common intervention was for aortoiliac occlusive diseases (UPA <italic toggle="yes">n</italic> = 66 vs. OPA <italic toggle="yes">n</italic> = 36). <xref rid="jcm-13-04179-f001" ref-type="fig">Figure 1</xref> represents the flowchart of the procedures performed on all patients.</p><p><xref rid="jcm-13-04179-t002" ref-type="table">Table 2</xref> presents the angiographic and intraoperative data. There is a significant difference in operation times between the two groups. The mean operation time for the percutaneous procedure was 164.5 &#177; 45.4 min, while the mean operation time for the cutdown procedure was 289.2 &#177; 79.4 min. The difference is statistically significant (<italic toggle="yes">p</italic> = 0.003). The longer operation time for the cutdown procedure is due to the additional steps required at both the beginning and end of the procedure. The comparison of mean sheath size and contrast material used in both groups showed similar results and were statistically insignificant (<italic toggle="yes">p</italic> &lt; 0.05). <xref rid="jcm-13-04179-t002" ref-type="table">Table 2</xref> also details the types of anesthesia and sheath sizes used in the procedures. At our institution, the preferred site for brachial access interventions, in both the percutaneous and cutdown groups, is typically the distal brachial artery, followed less frequently by the distal axillary and proximal brachail arteries (<xref rid="jcm-13-04179-t002" ref-type="table">Table 2</xref>).The overall technical success rate was 95% without any differences between the UPA (94%) and OSA (97%) procedures (<italic toggle="yes">p</italic> = 0.41). </p><p><xref rid="jcm-13-04179-t003" ref-type="table">Table 3</xref> lists the complications, procedures performed for complications, and mortality in the patients. Of the 485 patients, 449 had complete follow-up data available 30 days postoperatively. A total of 3 patients died within 30 days after the procedure, with 2 deaths in the UPA group (0.6%) and 1 in the OSA group (0.6%) (<italic toggle="yes">p</italic> = 0.131). The cause of death was not related to the access site or the procedure. No myocardial infarction occurred in either group. A stroke occurred in two patients, one in the UPA group and one in the OSA group. One patient in the UPA group developed a TIA. </p><p>Only two patients in the UPA group and one patient in the OSA group experienced infections at the intervention site. Nerve damage was observed in four patients in the UPA group and one patient in the OSA group (<italic toggle="yes">p</italic> = 0.045), with no permanent nerve injuries reported during follow-up. When comparing postprocedure hematoma rates, 15 patients in the UPA group and 2 in the OSA group developed hematomas, a statistically significant difference (<italic toggle="yes">p</italic> = 0.004). Thrombus formation occurred in nine patients in the UPA group and three in the OSA group, which was not statistically significant (<italic toggle="yes">p</italic> = 0.078). Pseudoaneurysm developed in 11 patients in the UPA group and 4 in the OSA group, with the difference not being statistically significant (<italic toggle="yes">p</italic> = 0.089). Overall, complications were observed in 32 (10%) of the UPA patients and 8 (4.8%) of the OSA patients, a statistically significant difference (<italic toggle="yes">p</italic> = 0.004). Reoperations were performed on 23 patients (7.2%) in the UPA group and 8 patients (4.8%) in the OSA group (<italic toggle="yes">p</italic> = 0.137). The procedures performed during the reoperations are detailed in <xref rid="jcm-13-04179-t003" ref-type="table">Table 3</xref>. The mean length of hospital stay for the patients is also compared in <xref rid="jcm-13-04179-t003" ref-type="table">Table 3</xref>. The 30-day mortality rate was 0.6% (2 patients) in the UPA group and 0.6% (1 patients) in the OSA group, with the difference not being statistically significant (<italic toggle="yes">p</italic> = 0.131).</p></sec><sec sec-type="discussion" id="sec4-jcm-13-04179"><title>4. Discussion</title><p>As endovascular interventions increase, surgeons continue to explore new sites for arterial access. In our study, patients who underwent interventions with brachial access were analyzed in two comparable groups: ultrasound-guided percutaneous (UPA) and open surgical incisional (OSA) approaches. UPA was associated with a higher incidence of access complications. We also reported that perioperative morbidity, including major adverse events and access site-related complications, was significantly lower in the OSA group. Additionally, there was a significant difference in operation times between the two groups. The mean operation time for the percutaneous procedure was 164.5 &#177; 45.4, while the mean operation time for the cutdown procedure was 289.2 &#177; 79.4. The difference is statistically significant (<italic toggle="yes">p</italic> = 0.003). This result is also emphasized by Bertoglio et al. This may be due to the complexity of endovascular procedures, the bigger sheath size, and the requirement of surgical exposure [<xref rid="B4-jcm-13-04179" ref-type="bibr">4</xref>]. However, mortality rates were statistically insignificant between the UPA and OSA groups (<italic toggle="yes">p</italic> = 0.131). The brachial access approach may be controversial due to the potential risks of upper limb ischemia, nerve injury, and stroke. In our study, all complications rates were 32 (10%) vs. 8 (4.8%), <italic toggle="yes">p</italic> = 0.004, respectively. On the other hand, brachial access is crucial in cases where femoral access is contraindicated or technically difficult, such as after kissing stent and bifurcated graft placement [<xref rid="B4-jcm-13-04179" ref-type="bibr">4</xref>,<xref rid="B6-jcm-13-04179" ref-type="bibr">6</xref>]. Despite its minimally invasive nature, studies have reported elevated complication rates. In a study by Alvarez-Tostado et al., complications related to access sites were seen in 21 out of 323 patients (6.6%), with surgical intervention required in 13 patients. Cutdown was performed in 29 patients (9%), with no complications observed in those who underwent the cutdown procedure [<xref rid="B7-jcm-13-04179" ref-type="bibr">7</xref>]. Madden et al. reported the use of percutaneous intervention primarily for diagnostic studies, presenting an access site complication rate of 10.6%, and concluded that an increased sheath size was associated with a higher risk of procedure complications [<xref rid="B8-jcm-13-04179" ref-type="bibr">8</xref>]. Other studies have indicated that complications in brachial interventions increase with sheath size, but open surgical interventions decrease this complication rate [<xref rid="B9-jcm-13-04179" ref-type="bibr">9</xref>]. Surgical incisions for brachial access may be appropriate before procedures requiring larger sheaths. To avoid complications, the smallest possible sheath should be used, and interventions should be performed with a cutdown incision if necessary. Stavroulakis et al. assessed the use of brachial access for endovascular treatment of iliac artery disease, demonstrating a 12% rate of access site-related adverse events [<xref rid="B10-jcm-13-04179" ref-type="bibr">10</xref>]. Another group reported an 8.7% access-related complication rate in open brachial access for iliac stenosis treatment [<xref rid="B11-jcm-13-04179" ref-type="bibr">11</xref>]. A literature analysis on OSA revealed lower access complication rates, ranging from 4% to 8%. Kret et al. also reported a 4.1% access complication rate after arterial cutdown, consistent with our study results of 35% for UPA vs. 13.3% for OSA [<xref rid="B9-jcm-13-04179" ref-type="bibr">9</xref>]. Bertoglio et al. found some procedural variables such as left-side access (<italic toggle="yes">p</italic> &lt; 0.001) were more frequently used in the percutaneous access group and elbow crease access (<italic toggle="yes">p</italic> &lt; 0.001) in the open surgical group. However, no significant differences were found between the groups after propensity matching [<xref rid="B4-jcm-13-04179" ref-type="bibr">4</xref>].</p><p>The primary endpoint, the access site complication rate, was significantly higher in the UPA group, despite the higher rate of 7 Fr sheath used in the OSA group. Reoperations due to occlusive complications were more frequently seen for surgical intervention. The level of sheath insertion may have a role in this AF [<xref rid="B7-jcm-13-04179" ref-type="bibr">7</xref>,<xref rid="B9-jcm-13-04179" ref-type="bibr">9</xref>]. The greater incidence of dual antiplatelet therapy in the UPA group could influence the results and increase the rate of access site complications. However, there were no statistically significant differences between the two groups regarding preoperative antiplatelet and anticoagulation therapy (for preoperative antiplatelet: 84% for UPA vs. 75.7% for OSA, <italic toggle="yes">p</italic> = 0.56; for anticoagulation: 14% for UPA vs. 12.1% for OSA, <italic toggle="yes">p</italic> = 0.609). Studies have not defined antiplatelet treatment as a potential risk factor for brachial access complications. Conversely, sheath size and female gender are known risk factors. Alvarez-Tostado&#8217;s study associated female gender with a higher complication rate (11.5% vs. 2.7% for males; <italic toggle="yes">p</italic> = 0.003) and higher brachial thrombosis rates [<xref rid="B7-jcm-13-04179" ref-type="bibr">7</xref>]. Kret et al. demonstrated that male gender (<italic toggle="yes">p</italic> &lt; 0.01), smaller sheath size (&lt;5 Fr; <italic toggle="yes">p</italic> = 0.03), and arterial cutdown (<italic toggle="yes">p</italic> = 0.04) were protective factors against access site complications [<xref rid="B9-jcm-13-04179" ref-type="bibr">9</xref>]. De Carlo et al. found a relationship between sheath size and access complication rate, with higher rates of brachial access complications in percutaneous interventions with larger sheaths [<xref rid="B12-jcm-13-04179" ref-type="bibr">12</xref>]. Patients with polyvascular disease do not fall into a single category with uniform risk.</p><p>The femoral arterial route remains the preferred option for most peripheral arterial interventions. To reduce perioperative access-related complications, various vascular closure devices have been developed, though they are primarily indicated for femoral artery use and have been evaluated at the brachial artery site in only a few studies [<xref rid="B13-jcm-13-04179" ref-type="bibr">13</xref>,<xref rid="B14-jcm-13-04179" ref-type="bibr">14</xref>,<xref rid="B15-jcm-13-04179" ref-type="bibr">15</xref>].</p><p>Currently, radial access is routinely used for the diagnosis and treatment of coronary artery disease [<xref rid="B3-jcm-13-04179" ref-type="bibr">3</xref>,<xref rid="B4-jcm-13-04179" ref-type="bibr">4</xref>,<xref rid="B5-jcm-13-04179" ref-type="bibr">5</xref>]. However, this approach is not always suitable for lower-limb vascular lesions due to the distance from the access site to the target vasculature. Coscas et al. reported 24 procedures using radial access, with a 13% radial artery occlusion rate and 2 radial artery ruptures treated by manual compression [<xref rid="B16-jcm-13-04179" ref-type="bibr">16</xref>]. The major limitation of radial access is the small diameter of the radial artery, which limits sheath sizes and poses a risk for artery occlusion [<xref rid="B16-jcm-13-04179" ref-type="bibr">16</xref>]. Kiemenj et al. compared percutaneous coronary interventions using radial, brachial, and femoral access with a 6 Fr sheath, demonstrating significantly higher rates of major complications with brachial and femoral approaches compared to radial access (2.3%, 2.0%, and 0%, respectively; <italic toggle="yes">p</italic> = 0.035) [<xref rid="B17-jcm-13-04179" ref-type="bibr">17</xref>]. New data are needed for patients who have suffered a stroke, aortic aneurysm, or peripheral artery disease (PAD). Additionally, there is a significant lack of data on subjects with polyvascular atherosclerotic disease, a population at very high risk. Accurate assessment is essential to stratifying risk in these patients. The possibility of effectively assessing cardiovascular risk in patients with polyvascular atherosclerotic disease using imaging techniques may be improved by correlating imaging data with metabolic targets or various medical therapies. This approach could verify the effectiveness of these therapies in preventing the progression of cardiovascular diseases (CVDs) [<xref rid="B18-jcm-13-04179" ref-type="bibr">18</xref>]. Cerebrovascular complications remain a significant obstacle for upper extremity access. Although there is no difference in stroke rates between various UEA closure techniques, future studies should determine whether avoiding upper extremity access could significantly reduce adverse events during complex aortic endovascular procedures [<xref rid="B19-jcm-13-04179" ref-type="bibr">19</xref>].</p><p>The major limitations of our study include its single-center, retrospective, and non-randomized design. It is not possible to report the number of patients for whom UEA was deemed infeasible during procedural planning by the physicians; thus, selection bias cannot be excluded. On the other hand, our center treats a huge number of patients annually and has substantial experience in obtaining upper extremity access. Furthermore, the option of a brachial arterial approach was at the discretion of the physicians, who routinely preferred the technique. Additionally, the study cohort includes patients who underwent a wide range of procedures using upper extremity brachial access, including arch and descending aorta repairs and treatments for infrarenal aortoiliac occlusive diseases. While this single-center retrospective study may have inherent biases, the physicians involved were experienced in both access techniques.</p></sec><sec sec-type="conclusions" id="sec5-jcm-13-04179"><title>5. Conclusions</title><p>The results of this study have revealed that the incidence of brachial access complications is higher for UPA than for OSA in patients undergoing endovascular arterial interventions. Further research should include a large-scale, randomized controlled trial to validate the potential advantages of OSA.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank Fulya Atak and Mustafa Kuyucu, members of the cardiovascular nursing team, and Barbaros Karadogan, a member of the hybrid technician team, for their invaluable efforts.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, A.K. and E.O.; methodology, E.O., N.D., A.K., C.B. and L.Y.; software, C.B.; validation, L.Y., C.B. and A.K.; formal analysis, E.O.; investigation, L.Y.; resources, E.O.; data curation, E.O., N.D., A.K., C.B. and L.Y.; writing&#8212;original draft preparation, E.O., N.D., A.K., C.B. and L.Y.; writing&#8212;review and editing, A.K.; visualization, L.Y.; supervision, A.K.; project administration, N.D.; funding acquisition, C.B. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>This study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Research Ethics Board at Ankara University (date: 28 August 2023, no. 2023/398).</p></notes><notes><title>Informed Consent Statement</title><p>Informed consent was obtained from all subjects involved in this study.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Data are contained within the article.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-jcm-13-04179"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knowles</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nation</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Timaran</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Gomez</surname><given-names>L.F.</given-names></name><name name-style="western"><surname>Baig</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Valentine</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Timaran</surname><given-names>C.H.</given-names></name></person-group><article-title>Upper extremity access for fenestrated endovascular aortic aneurysm repair is not associated with increased morbidity</article-title><source>J. Vasc. Surg.</source><year>2015</year><volume>61</volume><fpage>80</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2014.06.113</pub-id><pub-id pub-id-type="pmid">25095747</pub-id></element-citation></ref><ref id="B2-jcm-13-04179"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sch&#228;fer</surname><given-names>U.</given-names></name><name name-style="western"><surname>Deuschl</surname><given-names>F.</given-names></name><name name-style="western"><surname>Schofer</surname><given-names>N.</given-names></name><name name-style="western"><surname>Frerker</surname><given-names>C.</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kuck</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Kreidel</surname><given-names>F.</given-names></name><name name-style="western"><surname>Schirmer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mizote</surname><given-names>I.</given-names></name><name name-style="western"><surname>Reichenspurner</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Safety and efficacy of the percutaneous transaxillary access for transcatheter aortic valve implantation using various transcatheter heart valvesin 100 consecutive patients</article-title><source>Int. J. Cardiol.</source><year>2017</year><volume>232</volume><fpage>247</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2017.01.010</pub-id><pub-id pub-id-type="pmid">28118931</pub-id></element-citation></ref><ref id="B3-jcm-13-04179"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heenan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Grubnic</surname><given-names>S.</given-names></name><name name-style="western"><surname>Buckenham</surname><given-names>T.</given-names></name><name name-style="western"><surname>Belli</surname><given-names>A.-M.</given-names></name></person-group><article-title>Transbrachial arteriography: Indications and complications</article-title><source>Brain Lang.</source><year>1996</year><volume>51</volume><fpage>205</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/S0009-9260(96)80324-2</pub-id><pub-id pub-id-type="pmid">8605752</pub-id></element-citation></ref><ref id="B4-jcm-13-04179"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bertoglio</surname><given-names>L.</given-names></name><name name-style="western"><surname>Oderich</surname><given-names>G.</given-names></name><name name-style="western"><surname>Melloni</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gargiulo</surname><given-names>M.</given-names></name><name name-style="western"><surname>K&#246;lbel</surname><given-names>T.</given-names></name><name name-style="western"><surname>Adam</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Di Marzo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Piffaretti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Agrusa</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Eynde</surname><given-names>W.V.D.</given-names></name><etal/></person-group><article-title>Multicentre International Registry of Open Surgical versus Percutaneous Upper Extremity Access during Endovascular Aortic Procedures</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2023</year><volume>65</volume><fpage>729</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2023.01.046</pub-id><pub-id pub-id-type="pmid">36740094</pub-id></element-citation></ref><ref id="B5-jcm-13-04179"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>E.</given-names></name><name name-style="western"><surname>Warner</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Hnath</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Sternbach</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Darling</surname><given-names>R.C.</given-names><suffix>III</suffix></name></person-group><article-title>Percutaneous axillaryartery access for endovascular interventions</article-title><source>J. Vasc. Surg.</source><year>2018</year><volume>68</volume><fpage>555</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2017.11.066</pub-id><pub-id pub-id-type="pmid">29398309</pub-id></element-citation></ref><ref id="B6-jcm-13-04179"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mirza</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Steerman</surname><given-names>S.N.</given-names></name><name name-style="western"><surname>Ahanchi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Mushti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Panneton</surname><given-names>J.M.</given-names></name></person-group><article-title>Analysis of vascular closure devices after transbrachial artery access</article-title><source>Vasc. Endovasc. Surg.</source><year>2014</year><volume>48</volume><fpage>466</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1177/1538574414551576</pub-id><pub-id pub-id-type="pmid">25267690</pub-id></element-citation></ref><ref id="B7-jcm-13-04179"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alvarez-Tostado</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Moise</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Bena</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Pavkov</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Greenberg</surname><given-names>R.K.</given-names></name><name name-style="western"><surname>Clair</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Kashyap</surname><given-names>V.S.</given-names></name></person-group><article-title>The brachial artery: A critical access for endovascular procedures</article-title><source>J. Vasc. Surg.</source><year>2009</year><volume>49</volume><fpage>378</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2008.09.017</pub-id><pub-id pub-id-type="pmid">19028057</pub-id></element-citation></ref><ref id="B8-jcm-13-04179"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madden</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Calligaro</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Troutman</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Dougherty</surname><given-names>M.J.</given-names></name></person-group><article-title>Outcomes of Brachial Artery Access for Endovascular Interventions</article-title><source>Ann. Vasc. Surg.</source><year>2019</year><volume>56</volume><fpage>81</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.avsg.2018.07.061</pub-id><pub-id pub-id-type="pmid">30347242</pub-id></element-citation></ref><ref id="B9-jcm-13-04179"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kret</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Dalman</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Kalish</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mell</surname><given-names>M.</given-names></name></person-group><article-title>Arterial cutdown reduces complications after brachial access for peripheral vascular intervention</article-title><source>J. Vasc. Surg.</source><year>2016</year><volume>64</volume><fpage>149</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2016.02.019</pub-id><pub-id pub-id-type="pmid">27021376</pub-id></element-citation></ref><ref id="B10-jcm-13-04179"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stavroulakis</surname><given-names>K.</given-names></name><name name-style="western"><surname>Usai</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Torsello</surname><given-names>G.</given-names></name><name name-style="western"><surname>Schwindt</surname><given-names>A.</given-names></name><name name-style="western"><surname>Stachmann</surname><given-names>A.</given-names></name><name name-style="western"><surname>Beropoulis</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bisdas</surname><given-names>T.</given-names></name></person-group><article-title>Efficacy and safety of transbrachial access for iliac endovascular interventions</article-title><source>J. Endovasc. Ther.</source><year>2016</year><volume>23</volume><fpage>454</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1177/1526602816640522</pub-id><pub-id pub-id-type="pmid">27037217</pub-id></element-citation></ref><ref id="B11-jcm-13-04179"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nasr</surname><given-names>B.</given-names></name><name name-style="western"><surname>Albert</surname><given-names>B.</given-names></name><name name-style="western"><surname>David</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Khalifa</surname><given-names>A.</given-names></name><name name-style="western"><surname>El Aridi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Badra</surname><given-names>A.</given-names></name><name name-style="western"><surname>Braesco</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gouny</surname><given-names>P.</given-names></name></person-group><article-title>Endovascular treatment of atherosclerotic iliac stenosis: Local and systemic complications of the open brachial access</article-title><source>Ann. Vasc. Surg.</source><year>2016</year><volume>33</volume><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.avsg.2015.10.027</pub-id><pub-id pub-id-type="pmid">26802290</pub-id></element-citation></ref><ref id="B12-jcm-13-04179"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeCarlo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Latz</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Boitano</surname><given-names>L.T.</given-names></name><name name-style="western"><surname>Pendleton</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Mohebali</surname><given-names>J.</given-names></name><name name-style="western"><surname>Conrad</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Eagleton</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>S.I.</given-names></name></person-group><article-title>Percutaneous brachial access associated with increased incidence of complications compared with open exposure for peripheral vascular interventions in a contemporary series</article-title><source>J. Vasc. Surg.</source><year>2021</year><volume>73</volume><fpage>1723</fpage><lpage>1730</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2020.08.143</pub-id><pub-id pub-id-type="pmid">33031886</pub-id></element-citation></ref><ref id="B13-jcm-13-04179"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gou&#235;ffic</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Picquet</surname><given-names>J.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kaladji</surname><given-names>A.</given-names></name><name name-style="western"><surname>Marret</surname><given-names>O.</given-names></name><name name-style="western"><surname>Muller</surname><given-names>L.</given-names></name><name name-style="western"><surname>Guyomarc&#8217;h</surname><given-names>B.</given-names></name><name name-style="western"><surname>Riche</surname><given-names>V.-P.</given-names></name><name name-style="western"><surname>Chaillou</surname><given-names>P.</given-names></name><name name-style="western"><surname>Guillou</surname><given-names>M.</given-names></name><etal/></person-group><article-title>A Randomized Trial Comparing Polymer Versus Suture-Based Vascular Closure Devices for Arterial Closure Following Lower-Limb Arterial Endovascular Revascularization</article-title><source>Cardiovasc. Interv.</source><year>2017</year><volume>10</volume><fpage>1344</fpage><lpage>1354</lpage><pub-id pub-id-type="doi">10.1007/s00270-021-02940-z</pub-id><pub-id pub-id-type="pmid">34386892</pub-id></element-citation></ref><ref id="B14-jcm-13-04179"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gliech</surname><given-names>V.</given-names></name><name name-style="western"><surname>D&#252;bel</surname><given-names>H.P.</given-names></name><name name-style="western"><surname>Rutsch</surname><given-names>W.</given-names></name></person-group><article-title>Suture closure of the brachial artery access site post-coronary catheterization</article-title><source>J. Invasive Cardiol.</source><year>2001</year><volume>13</volume><fpage>12</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">11146679</pub-id></element-citation></ref><ref id="B15-jcm-13-04179"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belenky</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aranovich</surname><given-names>D.</given-names></name><name name-style="western"><surname>Greif</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bachar</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bartal</surname><given-names>G.</given-names></name><name name-style="western"><surname>Atar</surname><given-names>E.</given-names></name></person-group><article-title>Use of a Collagen-Based Device for Closure of Low Brachial Artery Punctures</article-title><source>Cardiovasc. Interv. Radiol.</source><year>2007</year><volume>30</volume><fpage>273</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1007/s00270-006-0061-4</pub-id><pub-id pub-id-type="pmid">17171307</pub-id></element-citation></ref><ref id="B16-jcm-13-04179"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coscas</surname><given-names>R.</given-names></name><name name-style="western"><surname>de Blic</surname><given-names>R.</given-names></name><name name-style="western"><surname>Capdevila</surname><given-names>C.</given-names></name><name name-style="western"><surname>Javerliat</surname><given-names>I.</given-names></name><name name-style="western"><surname>Go&#235;au-Brissonniere</surname><given-names>O.</given-names></name><name name-style="western"><surname>Coggia</surname><given-names>M.</given-names></name></person-group><article-title>Percutaneous radial access for peripheral transluminal angioplasty</article-title><source>J. Vasc. Surg.</source><year>2015</year><volume>61</volume><fpage>463</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2014.07.009</pub-id><pub-id pub-id-type="pmid">25135875</pub-id></element-citation></ref><ref id="B17-jcm-13-04179"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kiemeneij</surname><given-names>F.</given-names></name><name name-style="western"><surname>Laarman</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Odekerken</surname><given-names>D.</given-names></name><name name-style="western"><surname>Slagboom</surname><given-names>T.</given-names></name><name name-style="western"><surname>van der Wieken</surname><given-names>R.</given-names></name></person-group><article-title>A Randomized Comparison of Percutaneous Transluminal Coronary Angioplasty by the Radial, Brachial and Femoral Approaches: The Access Study</article-title><source>J. Am. Coll. Cardiol.</source><year>1997</year><volume>29</volume><fpage>1269</fpage><lpage>1275</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(97)00064-8</pub-id><pub-id pub-id-type="pmid">9137223</pub-id></element-citation></ref><ref id="B18-jcm-13-04179"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perone</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bernardi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Redheuil</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mafrica</surname><given-names>D.</given-names></name><name name-style="western"><surname>Conte</surname><given-names>E.</given-names></name><name name-style="western"><surname>Spadafora</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ecarnot</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tokgozoglu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Santos-Gallego</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Kaiser</surname><given-names>S.E.</given-names></name><etal/></person-group><article-title>Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions</article-title><source>J. Clin. Med.</source><year>2023</year><volume>12</volume><elocation-id>5563</elocation-id><pub-id pub-id-type="doi">10.3390/jcm12175563</pub-id><pub-id pub-id-type="pmid">37685628</pub-id><pub-id pub-id-type="pmcid">PMC10487991</pub-id></element-citation></ref><ref id="B19-jcm-13-04179"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Settembrini</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>K&#246;lbel</surname><given-names>T.</given-names></name><name name-style="western"><surname>Rohlffs</surname><given-names>F.</given-names></name><name name-style="western"><surname>Eleshra</surname><given-names>A.</given-names></name><name name-style="western"><surname>Debus</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Panuccio</surname><given-names>G.</given-names></name></person-group><article-title>Use of a Steerable Sheath for Antegrade Catheterization of a Supra-Aortic Branch of an Inner-Branched Arch Endograft via a Percutaneous Femoral Access</article-title><source>J. Endovasc. Ther.</source><year>2020</year><volume>27</volume><fpage>917</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1177/1526602820939936</pub-id><pub-id pub-id-type="pmid">32633652</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="jcm-13-04179-f001" orientation="portrait"><label>Figure 1</label><caption><p>Flowchart of the procedures. EVAR = abdominal endovascular aneurysm repair; TEVAR = thoracic endovascular aneurysm repair; FEVAR = fenestrated abdominal endovascular aneurysm repair.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-04179-g001.jpg"/></fig><table-wrap position="float" id="jcm-13-04179-t001" orientation="portrait"><object-id pub-id-type="pii">jcm-13-04179-t001_Table 1</object-id><label>Table 1</label><caption><p>Demographic data and comorbidities in patients.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percutaneous (<italic toggle="yes">N</italic> = 320)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cutdown (<italic toggle="yes">N</italic> = 165)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age (mean)</td><td align="center" valign="middle" rowspan="1" colspan="1">67.2</td><td align="center" valign="middle" rowspan="1" colspan="1">69.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.416</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BMI (mean)</td><td align="center" valign="middle" rowspan="1" colspan="1">26.7</td><td align="center" valign="middle" rowspan="1" colspan="1">28.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.114</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">182 (56.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">99 (60.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.246</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" rowspan="1" colspan="1">138 (43.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">66 (40.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.113</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Smoking</td><td align="center" valign="middle" rowspan="1" colspan="1">149 (46.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">104 (63.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.300</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diabetes mellitus</td><td align="center" valign="middle" rowspan="1" colspan="1">183 (57.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">92 (55.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.149</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" rowspan="1" colspan="1">172 (53.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">103 (62.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.172</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hypertension</td><td align="center" valign="middle" rowspan="1" colspan="1">208 (65.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">118 (71.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.345</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Prior CABG or PCI</td><td align="center" valign="middle" rowspan="1" colspan="1">124 (38.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">72 (43.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.254</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dialysis</td><td align="center" valign="middle" rowspan="1" colspan="1">45 (14.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">29 (17.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.656</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Preoperative antiaggregant</td><td align="center" valign="middle" rowspan="1" colspan="1">269 (84.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">125 (75.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preoperative anticoagulation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45 (14.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 (12.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.609</td></tr></tbody></table><table-wrap-foot><fn><p>Data are presented as <italic toggle="yes">n</italic> (%) or mean &#177; standard deviation. BMI = body mass index; COPD = chronic obstructive pulmonary disease; CABG = coronary artery bypass graft surgery; PCI = percutaneous coronary intervention.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jcm-13-04179-t002" orientation="portrait"><object-id pub-id-type="pii">jcm-13-04179-t002_Table 2</object-id><label>Table 2</label><caption><p>Angiographic and intraoperative characteristics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percutaneous<break/><italic toggle="yes">N</italic> = 320</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cutdown<break/><italic toggle="yes">N</italic> = 165</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Procedure time (min)</td><td align="center" valign="middle" rowspan="1" colspan="1">164.5 &#177; 45.4</td><td align="center" valign="middle" rowspan="1" colspan="1">289.2 &#177; 79.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.003</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sheath size (mean) (French)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.2 &#177; 1.7</td><td align="center" valign="middle" rowspan="1" colspan="1">8.1 &#177; 1.9</td><td align="center" valign="middle" rowspan="1" colspan="1">0.009</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Contrast agent volume (mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">55.6 &#177; 32.3</td><td align="center" valign="middle" rowspan="1" colspan="1">59.5 &#177; 36.7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.008</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Anesthesia</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="10" align="center" valign="middle" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Local</td><td align="center" valign="middle" rowspan="1" colspan="1">207 (64.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">59 (35.8)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Regional</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">13 (7.9)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">General</td><td align="center" valign="middle" rowspan="1" colspan="1">113 (35.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">93 (56.4)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sheath diameter</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5 French</td><td align="center" valign="middle" rowspan="1" colspan="1">19 (5.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6 French</td><td align="center" valign="middle" rowspan="1" colspan="1">219 (68.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">7 French</td><td align="center" valign="middle" rowspan="1" colspan="1">82 (25.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">5 (3.0)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8 French</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">134 (81.2)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9 French</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">26 (15.8)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Access or puncture site</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Distal axillary or proximal brachial</td><td align="center" valign="middle" rowspan="1" colspan="1">72 (22.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">28 (17.0)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elbow crease or distal brachial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">248 (77.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">137 (83.0)</td></tr></tbody></table><table-wrap-foot><fn><p>Data are presented as <italic toggle="yes">n</italic> (%) or mean &#177; standard deviation.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jcm-13-04179-t003" orientation="portrait"><object-id pub-id-type="pii">jcm-13-04179-t003_Table 3</object-id><label>Table 3</label><caption><p>Complications and management.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percutaneous<break/><italic toggle="yes">N</italic> = 320</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cutdown<break/><italic toggle="yes">N</italic> = 165</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Infection at access site</td><td align="left" valign="middle" rowspan="1" colspan="1">2 (0.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">1 (0.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.122</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Nerve injury</td><td align="left" valign="middle" rowspan="1" colspan="1">4 (1.3)</td><td align="left" valign="middle" rowspan="1" colspan="1">1 (0.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.045</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hematoma</td><td align="left" valign="middle" rowspan="1" colspan="1">15 (4.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">2 (1.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Thrombosis</td><td align="left" valign="middle" rowspan="1" colspan="1">9 (2.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">3 (1.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.078</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Pseudoaneurysm</td><td align="left" valign="middle" rowspan="1" colspan="1">11 (3.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">4 (2.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.089</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Reoperation</td><td align="left" valign="middle" rowspan="1" colspan="1">23 (7.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">8 (4.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.137</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">All Complications</td><td align="left" valign="middle" rowspan="1" colspan="1">32 (10.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">8 (4.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.004</td></tr><tr><td colspan="3" align="left" valign="middle" rowspan="1">Management</td><td rowspan="6" align="left" valign="middle" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Endovascular </td><td align="left" valign="middle" rowspan="1" colspan="1">7 (2.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">8 (4.8)</td></tr><tr><td colspan="3" align="left" valign="middle" rowspan="1">Surgical</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Thrombectomy</td><td align="left" valign="middle" rowspan="1" colspan="1">24 (7.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">4 (2.4)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hematoma drainage</td><td align="left" valign="middle" rowspan="1" colspan="1">21 (6.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">8 (4.8)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Patch repair</td><td align="left" valign="middle" rowspan="1" colspan="1">4 (1.3)</td><td align="left" valign="middle" rowspan="1" colspan="1">1 (0.6)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hospital stay (days)</td><td align="left" valign="middle" rowspan="1" colspan="1">8.43 &#177; 6.3</td><td align="left" valign="middle" rowspan="1" colspan="1">9.87 &#177; 8.78</td><td align="left" valign="middle" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mortality (30-day)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (0.6)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (0.6)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.131</td></tr></tbody></table><table-wrap-foot><fn><p>Data are presented as <italic toggle="yes">n</italic> (%) or mean &#177; standard deviation.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>